Chronic inflammation, which leads to colitis-associated cancer, is characterized by the production of proinflammatory cytokines that can induce mutations in oncogenes and tumor suppressor genes (APC, p53, and KRAS) and genomic instability via various mechanisms. This evidence concerns the gene TP53 and cancer.